Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05366166
Title Pembrolizumab Plus Olaparib in LA-HNSCC
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center

hypopharynx cancer

oral cavity cancer

laryngeal squamous cell carcinoma

oropharynx cancer


Cisplatin + Olaparib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UNC Lineberger Chapel Hill North Carolina 27514 United States Details
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 United States Details
*Shaded cells indicate that there was no data available from for the field